Synopsis of recent research by authors named "Uzma S Asghar"
Uzma S Asghar's research primarily focuses on breast cancer treatment, specifically evaluating the efficacy of CDK4/6 inhibitors in both hormone-positive and triple-negative breast cancer subtypes.
Her systematic review highlights the role of molecular biomarkers in predicting resistance to CDK4/6 inhibitors in metastatic breast cancer, providing insights into the therapeutic landscape for hormone-positive cases.
Additionally, her work on triple-negative breast cancer examines the variability in response to CDK4/6 inhibition among different cancer subtypes, aiming to identify mechanisms of sensitivity and resistance that could inform personalized treatment strategies.
